RankingsPricing
  1. US-listed companies
  2. SINOVAC BIOTECH LTD

SINOVAC BIOTECH LTDSVA

Market cap
P/E ratio
Back to summarized table
Income statementBalance sheetCash flow
Dec 31,
2011		Dec 31,
2013		Dec 31,
2014		Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022
Cash and cash equivalents1041079264621141581531,04111,6094,278
Total Restricted Cash---232-39118
Short-Term Investments------19501351,8067,035
Accounts receivable - net (note 6)18324139506674114253952537
Inventory, Net814191914202528106376181
Prepaid expenses and deposits211112521616115
Income tax receivable------3---72
Total current assets1321571551291342042843501,56014,91512,126
Property, Plant and Equipment, Net7668686467767174200903994
Prepaid Land Lease Payments-111010998884070
Intangible assets - net (note 10)----------10
Prepaid Expense, Noncurrent408,6560000000000
Long-Term Investments---------656661
Prepayments for acquisition of equipment------022065121
Deferred tax assets (note 15)--------275271
Operating Lease, Right-of-Use Asset-------78411559
Other non-current assets828,90211011----3
Total assets2162412392032112993704521,90116,74814,115
Short-Term Bank Loans and Notes Payable-------63330
Due to Related Parties, Current-3322--7624
Accounts Payable and Accrued Liabilities, Current30282323255950592111,021906
Income tax payable301239-2351,268-
Deferred Revenue, Current-15834353648018
Deferred Government Grants Current-0112223151315
Dividend payable (note 19)795,106------51117142
Operating Lease, Liability, Current-------14106
Total current liabilities41498058669358876802,4131,092
Deferred government grants (note 17)25753464454
Long-term bank loans (note 12)--------21312
Deferred tax liability--------3324242
Due to Related Parties, Noncurrent-----77165-
Lease liability (notes 11 and 13(b))-------68511253
Other Liabilities, Noncurrent--013332100
Total long-term liabilities304817615302013102459310
Total liabilities7197976482122781007812,8721,402
Preferred Stock, Value, Issued-------0000
Common Stock, Value, Issued54,7740000000000
Additional paid-in capital105107108110113115205208539548541
Subscriptions receivable--------77-
Accumulated other comprehensive income (loss)101412807-2-420131-383
Statutory surplus reserves (note 21)-------34501,5141,538
Accumulated earnings3---8-12924571447,1427,226
Total shareholders' equity1451441421391301772923521,12013,87612,713
Non-controlling interests15151515142638583744,5493,791
Total equity1451441421391301772923521,12013,87612,713
Total liabilities and equity2162412392032112993704521,90116,74814,115